Tarbox Family Office, Inc. Edwards Lifesciences Corp Transaction History

Tarbox Family Office, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$86.5 - $128.27 $37,887 - $56,182	-438 Closed	0 $0
Q1 2022 Apr 25, 2022	SELL	$101.96 - $128.34 $9,788 - $12,320	-96 Reduced 17.98%	438 $52,000
Q2 2020 Jul 23, 2020	BUY	$57.54 - $76.95 $22,210 - $29,702	386 Added 260.81%	534 $37,000
Q1 2020 Apr 30, 2020	SELL	$52.41 - $81.0 $1,467 - $2,268	-28 Reduced 15.91%	148 $28,000
Q4 2019 Jan 31, 2020	SELL	$71.7 - $82.09 $71 - $82	-1 Reduced 0.56%	176 $41,000
Q2 2019 Aug 02, 2019	BUY	$55.74 - $64.41 $3,232 - $3,735	58 Added 48.74%	177 $33,000
Q4 2018 Feb 01, 2019	BUY	$46.41 - $56.94 $5,522 - $6,775	119 New	119 $18,000
Q3 2018 Oct 29, 2018	SELL	$45.7 - $58.03 $2,742 - $3,481	-60 Closed	0 $0
Q4 2017 Jan 29, 2018	SELL	$33.79 - $39.39 $371 - $433	-11 Reduced 15.49%	60 $7,000
Q3 2017 Oct 19, 2017	BUY	$36.29 - $38.83 $2,576 - $2,756	71	71 $8,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Tarbox Family Office, Inc., based on Form 13F filings with the SEC.

Stay updated on Tarbox Family Office, Inc. with notifications on news.